AUCTORES
Globalize your Research
Chat with us
Mini Review | DOI: https://doi.org/10.31579/2641-0419/015
1 Universidade Federal de Mato Grosso do Sul, Mato Grosso do Sul, MS – Brazil
*Corresponding Author: Delcio G Silva Junior, Universidade Federal de Mato Grosso do Sul, Mato Grosso do Sul, MS – Brazil,
Citation: Silva Junior DG. (2019) Cardiovascular Disorders in Autoimmune Disease. Clin Cardiol Cardiovascular Interven 2(2): DOI: 10.31579/2641-0419/015
Copyright: © 2019 Silva Junior DG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 13 May 2019 | Accepted: 24 June 2019 | Published: 27 June 2019
Keywords: cardio vascular disease; systemic lupus erythematosus; autoimmune systemic inflammatory disease; coronary artery disease
The presence of Cardio Vascular Disease (CVD) impacts negatively on expectation and quality of life of the population, being one of the main causes of disability. Many of those who become cardiovascular patients throughout their life could have had different evolution if preventive attitudes were taken. Since 50’s decade, Framingham studies have shown the importance of predetermining factors for CVD occurrence. The classical CVD risk factors such as diabetes, metabolic syndrome, dyslipidemia, hypertension, smoking and family history are well established as predictors of cardiovascular events.
The presence of Cardio Vascular Disease (CVD) impacts negatively on expectation and quality of life of the population, being one of the main causes of disability. Many of those who become cardiovascular patients throughout their life could have had different evolution if preventive attitudes were taken. Since 50’s decade, Framingham studies have shown the importance of predetermining factors for CVD occurrence. The classical CVD risk factors such as diabetes, metabolic syndrome, dyslipidemia, hypertension, smoking and family history are well established as predictors of cardiovascular events.
However, in certain clinical conditions, traditional risk factors seem not to fully explain the incidence of CVD. Coronary artery disease and early atherosclerosis in young women with Systemic Lupus Erythematosus (SLE) are one of the best examples of how chronic inflammatory diseases can affect individuals who are normally poorly exposed to traditional risk factors. Even with the plurality of extra-articular manifestations of rheumatologic diseases, such as pulmonary hypertension and SLE encephalopathy, uveitis in spondyloarthritis, or as Achalasia in scleroderma, attention is being paid to the frequent cardiovascular system involvement in these patients, especially in the vascular territory
CVD - Cardio Vascular Disease; SLE - Systemic Lupus Erythematosus; AID - Autoimmune systemic Inflammatory Disease.
The involvement of the cardiovascular system in patients with Autoimmune systemic Inflammatory Disease (AID) is not limited to the arterial territory. Pericarditis, myocarditis, systolic or diastolic ventricular dysfunction, valvulopathies, aortic ectasia and pulmonary hypertension [2] are some of examples of cardiovascular extention involvement, and are not exclusively related to the presence of traditional risk factors. Gabriel, S.E. in 2010 [3] for example, has shown that traditional risk factors explain 80% of cases of heart failure in people without rheumatoid arthritis (RA), but in people with RA they would be related to only 40% of cases of heart failure.
The correlation between classic autoimmune diseases (rheumatoid arthritis, lupus and vasculitis) and CVD is well described in the literature. As raised by Van Doornum, McCool and Wicks in 2002, in RA, for example, there is a reduction of up to three times in survival, with ischemic heart disease being the leading cause of death [4]. Moreover, the risk of acute myocardial infarction in these patients is about two times higher than in the general population, and the prognosis after the event tends to be worse [5]. The meta-analysis of Avina-Zubieta et al. [6] with observational studies conducted between 1970 and 2005 gathered close to 112,000 patients with RA and found a 50% higher risk mortality in the RA group when compared to the control group. Schieir et al., in a meta-analysis involving the five major arthritis (rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), gout or osteoarthritis) found a 50% greater risk of infarction when adjusted only for sex and age. Even adjusted for one of the traditional risk factors, the higher risk of infarction (30%) shows that traditional risk factors only partially explain the greater chance of infarction in this population [7].
The characteristic exacerbated inflammatory process in autoimmune diseases, is intimately related to vascular lesions that contribute to the physiopathological process of several CVDs, which can be attended with vasculitis or accelerated atherosclerosis [8]. Atherosclerosis is already recognized as a consequence of the local or systemic endothelial inflammatory process, in which endothelial dysfunction, atherosclerotic plaque formation or even thrombosis begins in the expression of receptors in the endothelium, adhesion and infiltration of leukocytes and platelets [9]. Thus, accelerated atherosclerosis may be the main explanation for the high cardiovascular morbidity and mortality percentages in these patients [10].
The presence and persistence of inflammation should be seen as a key component for the occurrence of cardiovascular impairment and can be evaluated by several means, some of which are more strongly related to CVD. The C-reactive protein (CRP) is one of the most studied assessment risk factors. Its persistently increased levels constitute an independent risk factor for cardiovascular events, [11]. The late predictive value of CRP for cardiovascular events is also described in the literature, as verified in the GUSTO study [12], in which the authors showed a higher risk of mortality after 30 days of acute coronary event in patients with elevated CRP. The recent publication of the study CANTOS-Canakinumab Anti-inflammatory Thrombosis Outcomes Study [13] finally provided a proof of how the activity in the inflammatory factor is relevant to the prevention of CVD. In this double-blind randomized and controlled placebo study, in which 10061 patients after acute myocardial infarction (AMI) who persisted with elevated CRP (> 2mg) were treated with anti-IL1 monoclonal antibody, there was a 15% reduction in primary events (AMI, stroke or cardiovascular death).
Even in individuals in primary prevention, CRP can be used to re-stratify the risk as shown by Ridcker and collaborators in the validation of the Reynolds score [14]. Persistently increased PCR levels are associated with increased risk of myocardial infarction and stroke [15]. The plasmatic level of CRP, besides being an independent risk factor for cardiovascular events, adds risk potential to other factors such as LDL, for example, posing an associated Cardio Vascular (CV) risk increment [16]. The presence of elevated CRP is related not only to cardiovascular events but also to a worse prognosis for mortality, especially in the acute phase of ischemic heart disease, even serving as a risk assessment factor in CVD procedures [11].
The concept of the interaction between inflammation and CVD is reinforced by publications correlating other components of the inflammatory process with cardiopathy. Kaptoge et al. [17] showed that cytokines, especially interleukin 6, are independent markers for cardiovascular events, although there is still little to be affirmed about their of cause-effect relationship. IL-6 is released by Type 2 helper T lymphocytes, by antibody-presenting cells and by adipocytes, being a protein closely related to the inflammatory process and playing an important role in humoral response regulating, including PCR release, with lipid metabolism and glycemia interference, and markedly associated with metabolic syndrome. IL-6 has shown to be an attractive marker for providing information related not only to the inflammatory state but also to treatment response and future events occurrence [18].
That´s clear the remarkable participation of IL-6 on cardiovascular events [19] and its intimate pathophysiology involvement in atherosclerotic disease. Endothelial dysfunction due to chronic systemic inflammation predispose LDL infiltration. From there, monocytes migrate to the middle arterial layer, phagocyte the LDL transforming into macrophages and, by signaling to T lymphocytes, amplify the inflammatory process by releasing cytokines such as PCR-S and IL-6 [9]. Increased plasma levels of IL-6 are associated with a worse cardiovascular prognosis in patients with coronary disease, and are also more relevant in acute coronary scenario [20]. Persistently high IL-6 levels late to an acute coronary syndrome episode relates to worse prognosis [21]. Therefore, the role of inflammation as a contributor in the installation and evolution process of vascular disease is well established.
Stratification of Cardiovascular Risk in Autoimmune Disease
Although the highest incidence of CVD is recognized in patients with autoimmune disease, the investigation and risk stratification still await a better definition. While the treatments and diagnostic investigation in autoimmune diseases have evolved sharply in recent years, the approach of CVD in these patients did not have the same parallel. The existing general population risk scores for evaluation and conduct of CVD lack certification in the AID, in which the inflammatory environment can interfere in risk prediction capacity.
In 2010, the EULAR (European League against Rheumatism) has published an interesting document about it. EULAR, considering the most common forms of autoimmune disease like RA, SLE, psoriatic arthritis (PsA), suggests considering, besides the traditional risk factors for CVD, the inflammatory disease time, the presence of persistent inflammatory activity, and the occurrence of extra-articular manifestations [22]. Some patients should have their risk score multiplied by 1.5 for repunctuation (RA for more than 10 years, positive rheumatoid factor and extra-articular involvement). The document also recommends great control of the inflammatory scenario and caution when adopting NSAID and high doses of corticosteroids, reinforcing the importance of using statins and ACE inhibitors/ABRs in these individuals. Such recommendations have higher evidence in patients with SLE and RA, and are less significant in patients with SpA [22].
However, it has recently been shown that there is higher CV risk also in the SpAs (ankylosing spondylitis, PsA, reactive arthritis and enteropathy associated arthritis) even when considering the traditional risk factors, so that the presence of these diseases may also be considered additional risk factor for the occurrence of CVD. In an eight years follow-up, Bengtsson et al. compared almost 22 thousand patients with AS, PsA and SpAs with approximately 270 thousand control subjects, and found higher prevalence of CVD in the group with articular rheumatic disease. In general, the risk in SpAs was between 36% and 76% higher for ACS, and 50% higher for venous thromboembolism. The CVA risk was also higher in the spondyloarthritis group, with average risk ratio of 1.29 (from 1.06 to 1.48). These data reinforce the EULAR recommendations of considering SpAs also as CV risk aggravating [23].
We can see the best comprehension of what occurs in the publication of Crowson et al. [24], which shows that these risk factors explain just 70% of the CV events in patients with RA, being the last 30% of the events related to autoimmune disease and inflammatory activity.
Thus, the challenge when classifying the real risk for CVD in this population still needs to be better defined. The broad spectrum of immunological response, the variability of the inflammatory activity in each one of them and the use of medication with modifier role in the evolution of diseases interfere in the interpretation of studies, showing conflicting results in the topic.
Despite the recommendation of EULAR taskforce, there are still more recent arguments showing that it is necessary to better search for the presence of cardiopathy, especially of accelerated atherosclerosis, in patients with AID. Gomez-Vaquero et al. has shown that the European risk score SCORE and the Spanish risk score REGICOR, despite being good predictors of mortality and CV events in the general population, lose this potential in patients with RA, particularly when assessed by the presence of subclinical atherosclerosis [25].
In these patients, the general population risk scores have a less desired accuracy. Almost 50% of low risk SpAs patients classified by the Framingham score are reclassified to high risk when submitted to carotid ultrasound [26].
In order to achieve better stratification, other scores were developed to refine the risk assessment of CV in autoimmune diseases, such as the Expanded Cardiovascular Risk Prediction Score for RA (ERS-RA) that re-stratifies the impact of factors using information on AR activity level, disability, corticosteroid use and disease time, and the QRISK2, which considers the presence of RA as an independent risk factor.
These scores have failed to correctly assess the CV risk, especially when confronted with traditional scores [27]. As example, the ACC/AHA score proved to be incapable of identifying 55% of high-risk individuals when carotid ultrasound was used as an additional research method [28].
Approach and Investigation
The challenging CV risk assessment in AID patients does not seem to be enough attended by the available scores. Early stages of cardiovascular impairment may be observed in several autoimmune diseases and different complementary methods. Moreover, the cardiovascular system involvement is not limited to the arterial territory and can be present in various forms such as vasculitis, myocarditis, pericarditis, endocarditis, valvulopathies and arrhythmias. Aneurysmal dilatation of the aorta, aortic insufficiency and right bundle branch blocks are possibilities in AE. Myopericarditis and endocarditis are classic complications in SLE. Systolic heart failure and diastolic dysfunction can be found in RA. Thus, there are several forms of cardiovascular abnormality manifestation,that can be seen by different investigation methods.
The electrocardiogram is certainly the simplest and most economical complementary exam. It can be interesting in the follow-up of patients with spondyloarthritis where the branch blocks are more frequent, or in ischemia and necrosis identification in other kinds of AID. Despite its low cost and simplicity, it has very low specificity.
Echocardiography is a simple, low-cost and risk-free exam that can add valuable information on systolic and diastolic function, valvulopathies and pericardiopathies, common conditions in several AIDs. With Doppler method, it´s able to identify ventricular disfunction in early AID phases and related to the activity, severity and treatment response, especially in RA and SLE.
Myocardial scintillography can be used to assess coronary perfusion in patients with AID. Despite the possibility of abnormalities found due to classical atherosclerosis and their high sensitivity, the endothelial dysfunction of microcirculation can often cause non-specific alterations confounding with the presence of obstructive coronary artery disease. The radioactive concerns and higher cost add limitations on this method.
Angiotomography is well defined as a coronary lesions assessing method. It allows to evaluate beyond the coronary anatomy, the presence of plaques and calcium quantification score, which has a strong correlation with the cardiovascular risk prognostic. Patients with RA and SLE have a higher prevalence of valvular and coronary calcification, with higher prevalence and complexity of coronary plaques than controls [29]. It also allows scars and fibroses identification, as well as effusion and pericardial thickening. However, in addition to the high radioactivity employed, the method has lower tissue definition capacity, losing to magnetic resonance in fibrosis or amyloid infiltration differentiation for example, and both common in AID patients.
Magnetic resonance imaging (MRI) is particularly special in autoimmune diseases. Besides the advantages of not being radioactive and having less dependence on the operator evaluation, the method is able to identify characteristic myocardial edema in acute conditions, localized or focal fibrosis,damage in the epicardial, subendocardial or transmural region. It may identify obstructive atherosclerosis or microvascular disease. It can also differentiate fibrosis from other types of muscular infiltrates, reveal changes in contractility and diagnose pulmonary hypertension, common in autoimmune disease with prognostic relevance [30].
Therefore, in this diverse scenario of the AID, a well-performed echocardiogram may be enough. Carotid Doppler can contribute to a risk rescore at low cost in most cases, and make changes in the conduction of cardiovascular protection goals. Sometimes, the identification of perfusion by scintigraphy or stable chronic coronary atherosclerosis by CT may be preferable. On the other hand, the differentiation between acute inflammatory conditions, infiltrative cardiomyopathy or pulmonary hypertension by MRI should be taken into account.
Finally, like on other cardiopathies, the best complementary exam to evaluate the cardiovascular impairment depends not only on the AID type with its typical form of CV manifestation but also on the CV risk profile of each patient. Thus, the multiple assessing possibilities of CVD in AID patients may depend on available resources, experience of the service and what is intended to be evaluated. The multifaceted cardiovascular compromise in the AID aggregates chronic inflammation, specific evolution of each autoimmune disease, lifestyle components, genetics and medications effects. These factors can lead to varying degrees and types of CVD [31].
Autoimmune diseases are an independent risk factor for occurrence of cardiovascular disease. The association between traditional risk factors and inflammation is complex and multifarious, leading to different degrees of cardiovascular impairment. The best approach of CVD in the AID patients requires a broad evaluation of the autoimmune pathology with quantification of intensity and persistence of inflammation allied to traditional CVD risk factors stratification and different investigation methods.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
